Finanzas de MiniMed Group Inc (MMED)MMEDMiniMed Group Inc

MiniMed Group Inc (MMED) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is CGM, accounting for 50.2% of total sales, equivalent to $420.00M. Other significant revenue streams include Consumables and Pumps. Understanding this composition is critical for investors evaluating how MMED navigates market cycles within the Medical Equipment, Supplies & Distribution industry.

Evaluating the bottom line, MiniMed Group Inc maintains a gross margin of 55.16%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 0.36%, while the net margin is 0.12%. These profitability ratios, combined with a Return on Equity (ROE) of N/A, provide a clear picture of how effectively MMED converts its operational activities into shareholder value.

In the context of the broader market, MMED competes directly with industry leaders such as STVN and SHC. With a market capitalization of $6.68B, it holds a leading position in the sector. When comparing efficiency, MMED's gross margin of 55.16% stands against STVN's 29.51% and SHC's 54.44%. Such benchmarking helps identify whether MiniMed Group Inc is trading at a premium or discount relative to its financial performance.

The company has shown fluctuating revenue growth, with Q2 2026 revenue at 752 million USD, up from 724 million USD in Q4 2025. However, net income has been negative, with a loss of -185 million USD in Q4 2026, indicating significant financial pressure.